Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-06-11-Speech-2-234"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20020611.12.2-234"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
". – The EU Scientific Committee on Veterinary Measures relating to Public Health was asked to review its previous opinions of April 1999 and May 2000 in the light of any new information, including the results of the studies launched by the Commission. In its opinion of 10 April 2002 the committee confirmed the risks posed by growth-promoting hormones to consumers that it had identified in its earlier opinions. In particular the committee concluded in its 1999 opinion that for 17ß-oestradiol there was a substantial body of evidence that it has to be considered as a complete carcinogen and that it exerts both tumour-initiating and tumour-promoting effects. No safe threshold could be established for any of the six hormones evaluated, and prepubertal children are the group of greatest concern because of their extremely low levels of endogenous production of hormones.
It was also concluded in 1999 that the adverse effects included developmental, neurobiological, genotoxic and carcinogenic effects. In saying that "no amendments to those opinions are justified", the scientists confirmed the validity of the previous opinions. New evidence was reported on the disposition of esters of 17ß-oestradiol and their accumulation in edible animal body fats.
This evidence needs to be considered in any exposure assessment as well as the consequences of the newly recognised, more complex metabolisms for synthetic hormones such as trenbolone, zeronol and melengestrol acetates. The possible adverse effects on human health of these residual metabolites require further assessment.
Finally, recent evidence was noted regarding possible adverse environmental effects. The Commission considers that its approach to consumer protection in this area is fully justified by scientific advice. The Commission shares the honourable Member's views concerning the importance of transparency and credibility, which is why the committee's opinions are immediately published on the website of the Commission's Directorate-General for Health and Consumer Protection, together with other relevant information on this issue."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples